loadpatents
Patent applications and USPTO patent grants for Dang; Yongjun.The latest application filed is for "compound for treating neurodegenerative disorders".
Patent | Date |
---|---|
Compound For Treating Neurodegenerative Disorders App 20220249433 - Lu; Boxun ;   et al. | 2022-08-11 |
Method For Screening Compound For Treating Or Preventing Polyq-related Neurodegenerative Diseases App 20220170930 - Lu; Boxun ;   et al. | 2022-06-02 |
Artemisinin Analog, And Use, Method, And Composition For Promoting Lipid Catabolism And Improving Sugar Metabolism App 20190133997 - TANG; Qiqun ;   et al. | 2019-05-09 |
Potent immunosuppressive agents, derivatives and uses Grant 8,841,285 - Romo , et al. September 23, 2 | 2014-09-23 |
Potent Immunosuppressive Agents, Derivatives And Uses App 20110053994 - Romo; Daniel ;   et al. | 2011-03-03 |
Anticancer agents and use Grant 7,737,134 - Romo , et al. June 15, 2 | 2010-06-15 |
Potent immunosuppressive agents derivatives and use App 20070149581 - Romo; Daniel ;   et al. | 2007-06-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.